ARCHIVES

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

DePinho’s Letter to the AAUP

May 30, 2014

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says

November 4, 1994

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002